Breast Cancer: Targets and Therapy, Volume 16, Issue (2024)

Browse this journal

Breast Cancer: Targets and Therapy, Volume 16, Issue (2024)

See all volumes and issues
Volume 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009
Download citations Download PDFs

ORIGINAL RESEARCH

Article
Predictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer
Yu-Xiang Deng, Yu-Jie Zhao, Qiao-Hong Nong, Hong-Mei Qiu, Qiao-Li Guo & Hui Hu
Pages: 393-402
Published online: 23 Jul 2024
AbstractforPredictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer | Full Text | References | PDF (1 MB) | EPUB
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases
Lifeng Tang, Wei Zhang & Long Chen
Pages: 379-392
Published online: 23 Jul 2024
AbstractforBrain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases | Full Text | References | PDF (5.8 MB) | EPUB
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
Alexandra N McMahon, Eunkyung Lee, Cristiane Takita, Isildinha M Reis, Jean L Wright & Jennifer J Hu
Pages: 369-377
Published online: 23 Jul 2024
AbstractforMetabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients | Full Text | References | PDF (489.3 KB) | EPUB
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report
Grazia Lazzari, Ilaria Benevento, Antonietta Montagna, Barbara D’Andrea, Giuseppina De Marco, Giovanni Castaldo, Antonella Bianculli, Raffaele Tucciariello, Vito Metallo & Angela Pia Solazzo
Pages: 359-367
Published online: 15 Jul 2024
AbstractforBreast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report | Full Text | References | PDF (853.3 KB) | EPUB
  • 14 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
Jun Zhang, Shengjun Zhang, Minli Liu, Zhe Yang & Rong Huang
Pages: 347-358
Published online: 14 Jul 2024
AbstractforResearch Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer | Full Text | References | PDF (3.7 MB) | EPUB
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

SHORT REPORT

Case Report
Role of AURKB Inhibition in Reducing Proliferation and Enhancing Effects of Radiotherapy in Triple-Negative Breast Cancer
Sierra Pellizzari, Harjot Athwal, Anne Claudine Bonvissuto & Armen Parsyan
Pages: 341-346
Published online: 09 Jul 2024
AbstractforRole of AURKB Inhibition in Reducing Proliferation and Enhancing Effects of Radiotherapy in Triple-Negative Breast Cancer | Full Text | References | PDF (1.3 MB) | EPUB
  • 25 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker
Mehmet Emin Buyukbayram, Zekeriya Hannarici, Yakup Duzkopru, Aykut Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, Mehmet Bilici, Salim Basol Tekin & Doğan Yazılıtaş
Pages: 329-339
Published online: 02 Jul 2024
AbstractforThe Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker | Full Text | References | PDF (999.4 KB) | EPUB
  • 39 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells
Dedy Hermansyah, Siti Syarifah, Adi Muradi Muhar & Agung Putra
Pages: 319-328
Published online: 02 Jul 2024
AbstractforUnveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells | Full Text | References | PDF (2.8 MB) | EPUB
  • 39 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Analysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis
Zhitao Zhang, Huan Lan & Shuai Zhao
Pages: 305-318
Published online: 11 Jun 2024
AbstractforAnalysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis | Full Text | References | PDF (3.1 MB) | EPUB
  • 54 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial
Li Guo, Shi-Cui Hong, Xuan Wang, Sheng-Qi Wang, Neng Wang, Xiao-Qing Wei, Hong-Lin Situ & Zhi-Yu Wang
Pages: 289-303
Published online: 01 Jun 2024
AbstractforModulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial | Full Text | References | PDF (2.2 MB) | EPUB
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative Analysis of Women’s Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia’s Amhara Region Using Parametric Shared Frailty Models
Seid Fentaw, Anteneh Asmare Godana, Dawit Abathun & Dessie Melese Chekole
Pages: 269-287
Published online: 30 May 2024
AbstractforComparative Analysis of Women’s Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia’s Amhara Region Using Parametric Shared Frailty Models | Full Text | References | PDF (4.5 MB) | EPUB
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab
Qingqing Gu, Mingzhi Zhu, Yanyan Wang & Yuanting Gu
Pages: 253-268
Published online: 25 May 2024
AbstractforRetrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab | Full Text | References | PDF (5.6 MB) | EPUB
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC)
Xulei Sui, Peipei Feng, Xiaoyuan Sun, Peng Liang, Ying Liu & Guowei Zhang
Pages: 245-252
Published online: 24 Apr 2024
AbstractforCorrelation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC) | Full Text | References | PDF (550.7 KB) | EPUB
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Expression and Significance of LINC02418 in Breast Cancer
Yong-Hong Zhou & Jian-Yuan Huang
Pages: 233-243
Published online: 24 Apr 2024
AbstractforExpression and Significance of LINC02418 in Breast Cancer | Full Text | References | PDF (6.8 MB) | EPUB
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CLINICAL TRIAL REPORT

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Ji-Bin Li, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen-Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan & Qian-Jun Chen
Pages: 223-231
Published online: 12 Apr 2024
AbstractforDoes the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial | Full Text | References | PDF (1.1 MB) | EPUB
  • 110 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

LETTER

Letter to the Editor
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
Febie Irsandy Syahruddin, Prihantono & Mirna Muis
Pages: 221-222
Published online: 10 Apr 2024
CitationforSerum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter] | Full Text | References | PDF (272.6 KB) | EPUB
  • 60 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer
Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu & Yi-Xin Qi
Pages: 199-219
Published online: 12 Apr 2024
AbstractforIdentification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer | Full Text | References | PDF (19.8 MB) | EPUB
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Meixi Ye, Hao Xu, Jinhua Ding & Li Jiang
Pages: 181-197
Published online: 10 Apr 2024
AbstractforTherapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review | Full Text | References | PDF (1.7 MB) | EPUB
  • 157 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
Shuling Wang, Yuqin Chen, Weidong Li, Chunfang Hao, Li Zhang, Weipeng Zhao, Yehui Shi & Zhongsheng Tong
Pages: 163-179
Published online: 03 Apr 2024
AbstractforSerum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients | Full Text | References | PDF (9 MB) | EPUB
  • 152 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
Michelle Marie Ubowski, Ryan VanSice, Morgan Marriott, Matthew J Yacobucci & Lipika Chablani
Pages: 149-162
Published online: 28 Mar 2024
AbstractforAmplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer | Full Text | References | PDF (6.1 MB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
HER2 Low Expression in Primary Male Breast Cancer
Katleen Nobbe, Melanie Erices-Leclercq, Frank Foerster, Robert Förster, Stephan E Baldus, Christian Rudlowski, Lars Schröder & Sabine Lubig
Pages: 141-148
Published online: 28 Mar 2024
AbstractforHER2 Low Expression in Primary Male Breast Cancer | Full Text | References | PDF (2.3 MB) | EPUB
  • 197 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
Nelson Rangel, Iris Lorena Sánchez, Duván Sebastián Valbuena & Milena Rondón-Lagos
Pages: 127-139
Published online: 15 Mar 2024
AbstractforZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer | Full Text | References | PDF (5.9 MB) | EPUB
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients
Qin Ma, Yao-Bang Liu, Tong She & Xin-Lan Liu
Pages: 117-126
Published online: 08 Mar 2024
AbstractforThe Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients | Full Text | References | PDF (2.9 MB) | EPUB
  • 153 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
Sarah Sharman Moser, Lior Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, Gabriel Chodick & Nava Siegelmann-Danieli
Pages: 105-116
Published online: 05 Mar 2024
AbstractforClinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting | Full Text | References | PDF (1.7 MB) | EPUB
  • 148 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery
Qi Li, Cong Gao, Xinrui Zhao, Jiahui Li, Qinghong Shen & Li Chen
Pages: 91-103
Published online: 05 Mar 2024
AbstractforAn Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery | Full Text | References | PDF (1.2 MB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
Yuying Zhou, Wu Xue, Xinyu Meng, Adheesh Bhandari, Hanqian Zeng, Rajan KC, Suzita Hirachan & Erjie Xia
Pages: 71-89
Published online: 05 Mar 2024
AbstractforGNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer | Full Text | References | PDF (14.7 MB) | EPUB
  • 118 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fêde, Gustavo de Oliveira Bretas, Cristiano de Pádua Souza, Max Mano & Jesse Lopes da Silva
Pages: 51-70
Published online: 27 Feb 2024
AbstractforAntibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads | Full Text | References | PDF (1.8 MB) | EPUB
  • 474 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study
Fardeen Bhimani, Sophie Lin, Maureen McEvoy, Arianna Cavalli, Liane Obaid, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Areej Shihabi & Sheldon Feldman
Pages: 41-50
Published online: 20 Feb 2024
AbstractforDoes Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study | Full Text | References | PDF (1.7 MB) | EPUB
  • 131 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer
Chia‐Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu & Ching-Ting Wei
Pages: 23-39
Published online: 15 Jan 2024
AbstractforPretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer | Full Text | References | PDF (2.5 MB) | EPUB
  • 205 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
Jian Jin, Jie Li, Yonghong Liu, Qingfeng Shi, Bo Zhang, Yanting Ji & Pengfei Hu
Pages: 15-22
Published online: 08 Jan 2024
AbstractforThyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer | Full Text | References | PDF (2 MB) | EPUB
  • 379 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
Suheyla Ekemen, Ebru Bilir, Hagar Elsayed Akram Soultan, Sadia Zafar, Figen Demir, Babek Tabandeh, Sadik Toprak, Ozlem Yapicier & Cevayir Coban
Pages: 1-13
Published online: 02 Jan 2024
AbstractforThe Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors | Full Text | References | PDF (4.1 MB) | EPUB
  • 280 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases
Lifeng Tang et al.
Article | Published online: 23 Jul 2024
Open Access
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
Alexandra N McMahon et al.
Article | Published online: 23 Jul 2024
Open Access
Predictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer
Yu-Xiang Deng et al.
Article | Published online: 23 Jul 2024
Open Access
Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report
Grazia Lazzari et al.
Article | Published online: 15 Jul 2024
Open Access